UNASSIGNED: 278 Background: @entity1 with @entity157 ( @entity157 ) usually present with incurable @entity5 and advanced underlying @entity409 . Although guidelines exist to assess the quality of end of life (EOL) care for @entity5 @entity1 , little is known about EOL care for @entity157 @entity1 . Due to the complexity and multidisciplinary nature of the disease, we hypothesized that EOL care for @entity157 @entity1 differs from that delivered to other @entity5 @entity1 and may be heterogenous based on @entity1 characteristics and primary clinician specialty. METHODS: We assessed EOL @entity157 care through medical chart review of 188 consecutive @entity157 @entity1 treated at an academic tertiary care hospital who died between 2007 and 2013. Based on available data, EOL care and documentation was assessed per published guidelines. @entity1 , @entity96 characteristics, @entity5 treatments, symptom burden, and EOL care and documentation was compared by provider specialty. The odds of receiving @entity146 EOL care by provider specialty, @entity1 characteristics, and documentation measures were calculated. Using data from the Dartmouth Atlas Project, we compared results with EOL data for @entity5 @entity1 overall at our institution and nationally during a similar time frame. RESULTS: Fewer @entity157 @entity1 enrolled in hospice compared with @entity5 @entity1 overall at our institution, and nationally (36%, 49% and 55%, respectively). In addition, @entity157 @entity1 spent fewer days on hospice, spent more time in the hospital, and experienced more (and longer) intensive care unit admissions. Compared to those primarily cared for by other specialties, @entity157 @entity1 seen by an oncologist were more likely to have goals of care (GOC) documentation and to enroll in hospice. @entity1 never seen by an oncologist were more likely to have a @entity146 . English as a non-primary language and code status documentation were among factors associated with more @entity146 EOL care. CONCLUSIONS: At our institution, EOL care for @entity157 @entity1 is more @entity146 compared to @entity5 @entity1 overall and nationally. The subset of @entity157 @entity1 seen by oncology were more likely to meet EOL quality guidelines (GOC documentation and hospice enrollment). A better understanding of EOL practices for @entity157 may impact multidisciplinary care.

XXXX and end-of-life care.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient', 'Patient'] @entity96 :: ('MESH:D008113', 'Disease') :: ['HCC and liver disease'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer', 'tumors'] @entity146 :: ('MESH:D001523', 'Disease') :: ['psychiatric illness', 'aggressive'] @entity409 :: ('MESH:D008107', 'Disease') :: ['liver disease'] @entity157 :: ('MESH:D006528', 'Disease') :: ['HCC', 'hepatocellular carcinoma']
@entity157 :: (MESH:D006528,Disease) :: ['Hepatocellular carcinoma']
